Business Wire7 小时
Contineum Therapeutics Expands Clinical Development of PIPE-791 With FDA Authorization of ...
Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical stage biopharmaceutical company focused on discovering and developi ...